Results 201 to 210 of about 1,921,670 (307)

Research progress on the BAG3-HSP70 axis-mediated autophagy in acute myeloid leukemia. [PDF]

Front Cell Dev Biol
Liu Y, Wu T.
europepmc   +1 more source

ZFP36L1 Enhances Microglial Ferroptosis in Ischemic Stroke by Reducing FTO‐Mediated N6‐Methyladenosine Demethylation of ACSL1 mRNA

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Microglia play an important role in ischemic stroke (IS). However, the molecular regulatory mechanisms underlying microglial ferroptosis in IS remain incompletely understood. In this study, blood samples were collected from 20 IS patients and 15 healthy volunteers.
Ai‐Xia Song, Han‐Xu Jin, Yuan‐Xin Sun, Wen‐Hui Kou, Xiao‐Ning Niu, Huan‐Huan Wang, Ting‐Ting Zhong, Ping Gu   +7 more
wiley   +1 more source

Acute Myeloid Leukemia in a Patient With Xeroderma Pigmentosum: A Case Report. [PDF]

Clin Case Rep
Soryal M, Mahmoud Marey M, Hassan MA, El-Sayed R, Seyed EKA, Elghandour A.   +5 more
europepmc   +1 more source

The circulating metatranscriptome in acute myeloid leukemia patients: an RNA-seq reanalysis. [PDF]

Front Microbiomes
Nguyen ADD, Kern R, Dombrovski T, LaFramboise T.   +3 more
europepmc   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

Mass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik, Petr Lapcik, Pavla Bouchalova, Pavel Bouchal   +3 more
wiley   +1 more source

Outcomes with fractionated gemtuzumab ozogamicin in molecularly defined favorable-risk acute myeloid leukemia. [PDF]

Blood Cancer J
Chornenki N, Liu A, Abou Mourad Y, Altook R, Cherniawsky H, Chung S, Forrest D, Lad D, Kuchenbauer F, Nantel SH, Narayanan S, Nevill T, Rodrigo J, Roy C, Song K, Toze C, White J, Zhao E, Sanford D, Stubbins RJ.   +19 more
europepmc   +1 more source

Analysis of Carbohydrates and Glycoconjugates by Matrix‐Assisted Laser Desorption/Ionization Mass Spectrometry: An Update for 2023–2024

Mass Spectrometry Reviews, EarlyView.
ABSTRACT The use of MALDI mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this comprehensive review is the twelfth update of the original article published in 1999 and brings coverage of the literature to the end of 2024.
David J. Harvey
wiley   +1 more source

FGF18 mediates fibroblast-leukemia cross talk to promote acute myeloid leukemia progression.

Blood
Zhang W, Ye Z, Zhou X, Xiong P, Pan Y, Qiu J, Li M, Shen J, Li Y, Lu Y, Chen Y, Bai X, Xie X.   +12 more
europepmc   +1 more source

The Role of the Bone Marrow Microenvironment in the Pathogenesis of Acute Myeloid Leukemia. [PDF]

Biomedicines
Gottardi M, De Marchi F, Ciotti G, Basso M, Raimondi V, Ciminale V, Simonetti G, Ghetti M, Di Liddo R, De Marchi R, Abouzeid IA, Sperotto A.   +11 more
europepmc   +1 more source

JAK2 Variant and Parkinsonian Syndromes: Coincidence or Pathophysiological Link?

Movement Disorders Clinical Practice, EarlyView.
Abstract Background JAK2 variants are a hallmark of myeloproliferative neoplasms (MPNs), including polycythemia vera and essential thrombocythemia. These disorders are often associated with thrombotic and inflammatory complications. From a movement disorder perspective, chorea is a rare but well‐recognized neurological occurrence in this context ...
Elena Ardila Jurado, Koustubh Bavdhankar, Divyani Garg, Francesca Magrinelli, Huw R. Morris, Kailash P. Bhatia   +5 more
wiley   +1 more source